Over 60% of cancer patients worldwide receive some form of radiation therapy during their treatment journey, highlighting how crucial it is to understand the difference between external and internal radiation therapy. Under the expert care of Dr. Mathangi J, Senior Consultant & In-charge of Radiation Oncology at Gleneagles Cancer Institute, Bangalore, patients gain access to advanced, precise, and compassionate treatment methods designed to deliver optimal outcomes with minimal side effects.
Radiation therapy is a cornerstone of modern cancer treatment, using high-energy rays to destroy or damage cancer cells while sparing surrounding healthy tissues. Depending on the tumor type, location, and size, oncologists recommend either external radiation therapy or internal radiation therapy. Both methods are effective, but the approach, delivery, and impact differ significantly.
At Gleneagles Cancer Institute, Dr. Mathangi and her team use cutting-edge technologies like TrueBeam STx, Stereotactic Ablative Body Radiotherapy (SBRT), and Gated RapidArc to tailor treatment to each patient’s needs, ensuring a balance between efficacy and safety.
The difference between external and internal radiation therapy primarily lies in how and where the radiation is delivered:
While both techniques aim to eradicate cancer cells, they differ in radiation source placement, duration, and side-effect profiles. Dr. Mathangi carefully evaluates each patient’s condition to decide which modality or combination will yield the best outcome.
External radiation therapy uses advanced imaging guidance to deliver radiation from outside the body. Techniques such as Image-Guided Radiotherapy (IGRT) and Intensity-Modulated Radiotherapy (IMRT) allow for pinpoint accuracy, reducing damage to healthy tissue. This approach is ideal for cancers located in deep-seated or large areas such as the brain, lungs, or prostate.
Patients under Dr. Mathangi’s care benefit from technologies like RapidArc and DIBH-gated radiotherapy, which enhance precision while minimizing side effects.
Brachytherapy involves the placement of radioactive material directly inside or near the tumor. This method provides a highly targeted dose of radiation to cancer cells while sparing nearby healthy tissues. The procedure is especially effective for cancers such as prostate, cervical, uterine, and breast cancer.
Depending on the cancer type and location, various methods like seed implantation or temporary insertion of radiation sources may be used. In seed implantation, tiny radioactive pellets (seeds) are permanently placed inside the tumor, continuously emitting radiation for several weeks or months.
Another method, known as high-dose-rate (HDR) brachytherapy, involves temporary radiation source placement using catheters or applicators, which are later removed after delivering the prescribed dose.
Systemic radiation is another internal therapy approach where radioactive substances are administered orally or intravenously to target cancer cells throughout the body. It’s often used for thyroid cancer or cancers that have spread to bones. Under Dr. Mathangi’s supervision, patients undergoing systemic treatments receive personalized monitoring to ensure both safety and efficacy.
A key factor influencing treatment choice is the side effect comparison between external and internal methods. Although both therapies may cause fatigue or localized discomfort, their intensity and duration vary.
| Parameter | External Radiation Therapy | Internal Radiation Therapy (Brachytherapy) |
|---|---|---|
| Delivery Method | Radiation directed externally using machines | Radiation delivered internally via sources placed near tumor |
| Duration | Multiple sessions over several weeks | Few sessions; sometimes a single treatment |
| Side Effects | Skin redness, fatigue, tissue inflammation | Localized discomfort, mild swelling, temporary irritation |
| Precision | High, but dependent on imaging and setup | Very high due to direct placement of radiation |
At Gleneagles Cancer Institute, Dr. Mathangi treats a wide range of cancers requiring radiation therapy including:
With over 12,000 successfully treated patients and international training from Germany and Denmark, Dr. Mathangi has mastered modern techniques in brachytherapy, systemic radiation, and advanced targeted dose delivery. Her department houses Asia Pacific’s first TrueBeam STx system, allowing for exceptional treatment precision and shorter recovery times.
Beyond her clinical achievements, Dr. Mathangi is also the Director of Fellowship in Advanced Radiotherapy Techniques under RGUHS, mentoring the next generation of radiation oncologists. Her patient-first philosophy ensures that every individual receives personalized care that combines medical excellence with empathy.
If you or a loved one needs expert evaluation or guidance on radiation therapy, you can submit your contact information through Dr. Mathangi’s official website. Her team will review your case and schedule your consultation at the earliest.
Dr. Mathangi J is a Senior Consultant & In-charge of Radiation Oncology at Gleneagles Cancer Institute, Bangalore. She specializes in advanced radiation therapy for head and neck cancers, prostate cancers, brain tumors, and women’s cancers. Her expertise in brachytherapy and systemic radiation has established her as a leading name in the field of oncology across South India.
External therapy delivers beams from a machine outside the body, while internal therapy places a source close to the tumour. Under Dr. Mathangi’s care, candidates are assessed for tumour site, size, and organ proximity so the right modality is selected, the plan is precise, and recovery guidance is clear. This balanced explanation reflects the difference between external and internal radiation therapy as it applies to real patients in Bangalore.
For personalised advice, book through drmathangi.com/contact/.
brachytherapy places a small radioactive source inside or next to the tumour using imaging guidance. Dr. Mathangi may recommend it for prostate, cervix, or select head & neck sites where precise local control is required and organ sparing is critical. It can be delivered as temporary high-dose-rate sessions or as permanent seeds, depending on diagnosis and anatomy.
systemic radiation uses a radioactive drug that circulates through the bloodstream to bind to cancer cells—useful when disease is diffuse or has specific molecular targets. In contrast, local implants act only where they’re placed. Dr. Mathangi evaluates disease spread, receptor targets, safety profile, and logistics before recommending one or the other.
seed implantation places tiny radioactive seeds permanently inside the tumour, most commonly in prostate cancer. The seeds deliver radiation steadily over time right where it’s needed. For selected patients, Dr. Mathangi may recommend this approach to optimise tumour control while limiting dose to nearby bladder and rectum.
Planning includes ultrasound or CT guidance, anaesthesia planning, post-implant dosimetry, and clear aftercare instructions.
Safe radiation source placement relies on imaging (ultrasound, CT, MRI), sterile technique, and a treatment plan that maps exact coordinates relative to critical organs. Dr. Mathangi’s team uses advanced planning systems, in-procedure verification, and post-placement quality checks to confirm the plan is followed precisely and that comfort measures are in place.
A targeted dose is a carefully shaped radiation distribution that concentrates energy in tumour tissues while sparing healthy structures. With techniques like IMRT, IGRT, SBRT, and brachytherapy, Dr. Mathangi tailors beam angles, dose rates, and margins to reduce collateral exposure and maintain organ function—especially vital in head & neck, lung, and pelvic cancers.
This precision helps improve control rates and quality of life during and after therapy.
A practical side effect comparison: external beams may cause skin changes or fatigue in the treated region; internal implants may produce transient local discomfort or require brief precautions depending on dose and isotope. Systemic options may call for safety counselling at home. Dr. Mathangi’s team anticipates these effects, provides supportive care plans, and adapts doses to your goals and daily routine.
Discuss your job demands, caregiving roles, and travel limits—your plan can be matched to your life, not the other way around.
Expect a clear consult that outlines your diagnosis, goals, and options, with timelines and expected outcomes. You’ll receive a written plan, counselling on logistics (work leave, transport, nutrition), and direct scheduling support. Start by submitting your details at drmathangi.com/contact/; her team will coordinate the next steps.
Your information is kept strictly confidential.
